Adrenoleukodystrophy, Neonatal
Oncology·MeSH: Medium chain acyl CoA dehydrogenase deficiency
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Adrenoleukodystrophy, Neonatal?
There are 1 clinical trial targeting Adrenoleukodystrophy, Neonatal tracked by BioSniper.
What is the prevalence of Adrenoleukodystrophy, Neonatal?
The estimated prevalence of Adrenoleukodystrophy, Neonatal is approximately 5.0 per 100,000 population.
Deep-dive into Adrenoleukodystrophy, Neonatal
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis